Our peptide therapy program stands out because we're transparent about what is and isn't FDA-approved

Key Points Activation of the androgen receptor (AR) is crucial for tumor cell progression and survival of prostate cancer, and androgen deprivation therapy remains the main clinical approach in men with locally advanced tumors Current therapies incompletely suppress the androgenAR axis, but a multiple therapeutic approach, targeting androgens and their receptor, has potential to improve clinical outcomes Treatment of prostate cancer cells with 5-reductase inhibitors (5ARIs) inhibits cellular pathways regulating metabolism, cell growth and proliferation, triggering apoptosis and decreasing prostate size Although 5ARI treatment reduces the risk of developing prostate cancer, patients treated with these drugs have tumors with higher Gleason scores than those who receive placebo Use of 5ARIs to prevent and treat prostate cancer remains controversial, and further investigation is necessary to understand the presence of more-aggressive tumors in patients receiving these drugs This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Strengthening the Skin Barrier and Hydration Inflammation and a weakened barrier go hand-in-hand
Remember: side effects are temporary, results are substantial
Expanded Scope for New Injection Methods or Techniques As medical technology advances, new injection devices and techniques such as on-body injectors, novel delivery systems, or specialty formulations may become more common
However, for the most accurate and reproducible scientific results, it should still be reconstituted strictly according to guidelines and stored at 28C after mixing